Urinary Tract Infection Testing

Global Urinary Tract Infection Testing Market to Reach ## by 2030

The global market for Urinary Tract Infection Testing estimated at ## in the year 2024, is expected to reach ## by 2030, growing at a CAGR of 0.0% over the analysis period 2024-2030.

Global Urinary Tract Infection (UTI) Testing Market – Key Trends & Drivers Summarized

Is the Rising Global Burden of UTIs Fueling a Surge in Diagnostic Demand?

Urinary tract infections (UTIs) are among the most common bacterial infections globally, impacting hundreds of millions of people annually and leading to a substantial increase in diagnostic testing. The growing incidence of UTIs across all age groups—particularly among women, the elderly, and individuals with diabetes, kidney conditions, or immunocompromised states—is driving sustained demand for rapid and accurate testing solutions. As awareness of early diagnosis and antimicrobial stewardship increases, healthcare systems are investing more in point-of-care diagnostics to reduce the burden on hospitals and minimize the overprescription of antibiotics. Recurrent and complicated UTIs, often associated with catheter use or structural abnormalities in the urinary tract, further contribute to the growing volume of diagnostic procedures in both inpatient and outpatient settings. Additionally, the global rise in healthcare-acquired infections (HAIs), particularly in long-term care facilities, is heightening the need for reliable UTI screening protocols. As clinicians aim to differentiate between asymptomatic bacteriuria and true infection, demand is shifting toward more specific and sensitive tests that can accurately guide treatment decisions. This evolving clinical landscape is pushing diagnostic laboratories, primary care providers, and urgent care centers to expand their capabilities in UTI detection, driving growth in the global UTI testing market.

How Are Technological Advancements and POC Diagnostics Transforming UTI Testing?

Technological innovation is dramatically reshaping the urinary tract infection testing landscape, with a growing emphasis on speed, accuracy, and accessibility. Traditional culture-based methods, though highly reliable, require 24–48 hours for results and are gradually being supplemented or replaced by rapid diagnostics. Modern urine dipstick tests and urinalysis kits now offer quicker detection of nitrites, leukocyte esterase, and other key indicators of infection, making them valuable tools in emergency departments and primary care settings. Additionally, molecular diagnostics—particularly PCR-based tests—are enabling the rapid identification of specific pathogens and resistance genes, significantly improving the precision of diagnosis and supporting appropriate antibiotic prescribing. Point-of-care (POC) platforms are becoming increasingly popular due to their portability, user-friendliness, and ability to deliver real-time results, particularly in rural or resource-limited environments. Automated urine analyzers are also being integrated into clinical laboratories to streamline workflows, reduce manual error, and allow for high-throughput testing. Furthermore, smartphone-connected devices and AI-driven diagnostic tools are emerging as novel solutions for home-based UTI monitoring, especially for patients with chronic or recurrent infections. These technological advancements are not only optimizing diagnostic accuracy but also helping clinicians move toward evidence-based, individualized treatment strategies, ultimately reducing the burden of antibiotic resistance and recurrent infections.

Are Shifting Healthcare Models and Consumer Behaviors Expanding the Market for UTI Testing?

As healthcare systems evolve toward decentralized, patient-centered care, urinary tract infection testing is increasingly being conducted in non-traditional settings such as retail clinics, home testing environments, and telehealth-driven diagnostic platforms. Consumers today demand convenience, speed, and confidentiality—especially for sensitive conditions like UTIs. This has led to the proliferation of at-home UTI test kits, which can be purchased over the counter or online, offering privacy and rapid self-screening. These kits often utilize colorimetric strip technologies or app-connected sensors that help users interpret results accurately and decide when to seek medical attention. Telemedicine providers have also embraced UTI testing as a high-demand service, often prescribing antibiotics based on symptoms and test confirmations without the need for an in-person visit. Additionally, employers and universities are offering UTI screening services as part of occupational health and wellness programs, further expanding testing beyond traditional clinical environments. On the institutional side, the emphasis on early detection and infection control in hospitals, nursing homes, and rehabilitation centers is driving routine screening and post-catheterization monitoring. This expansion of care settings—alongside greater patient involvement in health management—is fostering a dynamic and rapidly diversifying market for UTI testing, encouraging the development of new test formats and distribution models to meet this demand.

What Is Driving the Global Growth of the Urinary Tract Infection Testing Market?

The growth in the urinary tract infection testing market is driven by multiple converging factors tied to clinical need, technological progress, demographic trends, and healthcare delivery evolution. A major driver is the global increase in UTI prevalence, particularly among women, the elderly, and individuals with chronic illnesses or indwelling catheters, all of whom represent a consistent and expanding patient base. In parallel, rising awareness around the dangers of untreated UTIs—such as kidney infections, sepsis, and chronic recurrence—is prompting earlier and more frequent testing. The acceleration of antimicrobial resistance is also encouraging more precise diagnosis before antibiotic prescription, pushing healthcare providers to adopt rapid and pathogen-specific tests. The growing role of molecular and digital technologies, combined with the increased availability of affordable point-of-care and home-based test kits, is enhancing diagnostic reach and reducing access barriers. Favorable regulatory frameworks, supportive reimbursement policies, and public health initiatives promoting infectious disease surveillance are creating an enabling environment for testing innovation and market growth. Furthermore, the rise of telehealth, mobile diagnostics, and diagnostic-as-a-service (DaaS) platforms is expanding the availability of UTI testing to remote and underserved populations. As these trends continue to evolve, the urinary tract infection testing market is poised for strong and sustained expansion, driven by the combined imperatives of clinical urgency, patient empowerment, and diagnostic innovation.

SCOPE OF STUDY:

The report analyzes the Urinary Tract Infection Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type (Urethritis, Cystitis, Pyelonephritis); End-Use (General Practitioners, Urologists, Urogynecologists, Hospital Laboratories, Reference Laboratories, Hospital Emergency Departments, Urgent Care, Others)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

• Accelerate Diagnostics, Inc.
• Acutis Diagnostics
• Becton, Dickinson and Company (BD)
• Beckman Coulter
• bioMérieux
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• DiaSorin
• F. Hoffmann-La Roche Ltd.
• GENETWORx
• Healthy.io
• Patients Choice Laboratories
• QIAGEN
• Randox Laboratories Ltd.
• Siemens Healthineers
• T2 Biosystems, Inc.
• TestCard
• Thermo Fisher Scientific, Inc.
• Uritest Medical
• Winx

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.